Archery: Indian Compound Mixed Team Enters Final Of World Cup Stage 2 At Yecheon In South Korea

India’s Jyothi Surekha Vennam and Priyansh have entered the compound mixed team final at the Archery World Cup Stage 2 at Yecheon in South Korea today. The team defeated the host country’s duo of Han Seungyeon and Yang Jaewon in a tight semi-final.

With this, India has confirmed its second medal in the tournament after the Compound women’s team of Jyothi, Parneet Kaur, and Aditi Swami entered the final on Wednesday. Jyothi and Priyansh will now face USA’s Olivia Dean and Sawyer Sullivan in a clash of the top two world-ranked nations in the gold medal match tomorrow. Prathamesh Fuge has also advanced to the semifinal in the individual category.

Early in the first week of April, Daniel Vettori was out contextualising what a good performance would be for his bowlers. “If you give me eight-an-over, I’ll take it gladly” he said ahead of facing CSK at home as the definition of batting in the tournament had already started to morph. This came a week after his batters plundered 277 in Hyderabad, and carried on in the same vein in the games ahead. As the tournament progressed and SRH snared batting records, a clear narrative emerged – this is how a Pat Cummins team will play in the IPL.

There were upsides to this approach, as evidenced over the last two months. In wins, SRH had the best strike rate – 189.51. But most of their defeats were equally sapping. SRH either fly or crash and burn – there has been no middle ground or an ability to limit damages so far, which should pique the interest of Rajasthan Royals.

Sanju Samson’s side arrived in Chennai having made a mockery of the notion of ‘momentum’, proving once again why knockouts always start with a blank slate. A four-game rut was wiped out in one evening against RCB, hurling them in the path of the tournament’s pace-setters. Cummins was quick to shrug off the defeat to KKR in Q1, but it showed SRH were equally capable of being humbled as they were of inflicting that feeling on the opposition. RR, with their recent clinicality, will hope to tap into that.